[Diagnosis related groups in stroke treatment. An analysis from the stroke data bank of the German Stroke Foundation]

C Weimar1, J Stausberg, K Kraywinkel

  • 1Neurologische Klinik, Universität Essen. stroke.med@uni-essen.de

Insights

The Australian Refined Diagnosis Related Groups (AR-DRG) system may decrease hospital proceeds in German neurology departments and for transient ischemic attack (TIA) treatment. Adjustments are needed to maintain acute stroke care quality.

Area of Science:

  • Health Economics
  • Neurology
  • Hospital Management

Context:

  • Germany is introducing Diagnosis Related Groups (DRG) for hospital reimbursement.
  • Accurate cost data analysis is crucial for the transition.
  • Stroke treatment costs require specific evaluation.

Purpose:

  • To compare Australian Refined Diagnosis Related Groups (AR-DRG) cost weights with actual per-day rates for stroke treatment in Germany.
  • To assess the financial impact of AR-DRG implementation on neurology departments and TIA cases.

Summary:

  • A prospective study analyzed data from 6520 stroke and TIA patients across various German departments.
  • Cost weights were calculated using ICD-10-SGB-V 2.0 and MBS-Extended, compared against per-day rates.
  • Results indicate good homogeneity of cost weights relative to length of stay.

Impact:

  • Implementing AR-DRG with a uniform base rate may reduce hospital proceeds in neurology and for TIA treatment.
  • Maintaining the current acute stroke care structure necessitates supplementary measures beyond a uniform base rate for neurology departments.
Abstract